These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3736130)

  • 1. Urinary hyaluronic acid elevation in Hutchinson-Gilford progeria syndrome.
    Zebrower M; Kieras FJ; Brown WT
    Mech Ageing Dev; 1986 Jun; 35(1):39-46. PubMed ID: 3736130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of urinary hyaluronic acid in Werner's syndrome and progeria.
    Kieras FJ; Brown WT; Houck GE; Zebrower M
    Biochem Med Metab Biol; 1986 Dec; 36(3):276-82. PubMed ID: 3801210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronuria in a case of progeria. (Hutchinson-Gilford syndrome).
    Tokunaga M; Wakamatsu E; Sato K; Satake S; Aoyama K; Saito K; Sugawara M; Yosizawa Z
    J Am Geriatr Soc; 1978 Jul; 26(7):296-302. PubMed ID: 659773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome.
    Gordon LB; Harten IA; Calabro A; Sugumaran G; Csoka AB; Brown WT; Hascall V; Toole BP
    Hum Genet; 2003 Jul; 113(2):178-87. PubMed ID: 12728312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis by high-performance liquid chromatography of hyaluronic acid and chondroitin sulfates.
    Zebrower ME; Kieras FJ; Brown WT
    Anal Biochem; 1986 Aug; 157(1):93-9. PubMed ID: 3094400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hutchinson-Gilford progeria syndrome: a pathologic study.
    Ackerman J; Gilbert-Barness E
    Pediatr Pathol Mol Med; 2002; 21(1):1-13. PubMed ID: 11842974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
    Wei DC; Politano VA; Selzer MG; Lokeshwar VB
    J Urol; 2000 May; 163(5):1577-83. PubMed ID: 10751891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hutchinson-Gilford syndrome.
    Stables GI; Morley WN
    J R Soc Med; 1994 Apr; 87(4):243-4. PubMed ID: 8182686
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyaluronic acid in progeria and the aged phenotype?
    Sweeney KJ; Weiss AS
    Gerontology; 1992; 38(3):139-52. PubMed ID: 1624142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of adult and childhood progerias: Werner syndrome and Hutchinson-Gilford progeria syndrome.
    Brown WT; Kieras FJ; Houck GE; Dutkowski R; Jenkins EC
    Adv Exp Med Biol; 1985; 190():229-44. PubMed ID: 3909767
    [No Abstract]   [Full Text] [Related]  

  • 11. Progeria: a human-disease model of accelerated aging.
    Brown WT
    Am J Clin Nutr; 1992 Jun; 55(6 Suppl):1222S-1224S. PubMed ID: 1590260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome.
    Gerhard-Herman M; Smoot LB; Wake N; Kieran MW; Kleinman ME; Miller DT; Schwartzman A; Giobbie-Hurder A; Neuberg D; Gordon LB
    Hypertension; 2012 Jan; 59(1):92-7. PubMed ID: 22083160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthetic considerations in children with Hutchinson-Gilford progeria syndrome: A narrative review.
    Nijs K; Van de Velde M; Hoogma D
    Paediatr Anaesth; 2020 May; 30(5):537-543. PubMed ID: 32128928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development.
    Gordon LB; McCarten KM; Giobbie-Hurder A; Machan JT; Campbell SE; Berns SD; Kieran MW
    Pediatrics; 2007 Oct; 120(4):824-33. PubMed ID: 17908770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC glycosaminoglycan analysis in patients with Graves' disease.
    Hansen C; Fraiture B; Rouhi R; Otto E; Förster G; Kahaly G
    Clin Sci (Lond); 1997 May; 92(5):511-7. PubMed ID: 9176026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronans: crystallization-promoting activity and HPLC analysis of urinary excretion.
    Shum DK; Gohel MD; Tam PC
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S397-403. PubMed ID: 10541272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progeria.
    Badame AJ
    Arch Dermatol; 1989 Apr; 125(4):540-4. PubMed ID: 2649013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
    Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
    Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.
    Lokeshwar VB; Obek C; Soloway MS; Block NL
    Cancer Res; 1997 Feb; 57(4):773-7. PubMed ID: 9044859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyaluronic acid and N-terminal procollagen-III-peptide in the urine in inflammatory and degenerative joint diseases].
    Respondek M; Seibel MJ; Lautenschläger J; Müller W
    Z Rheumatol; 1989; 48(3):117-22. PubMed ID: 2789456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.